Skip to main content
. 2020 Aug 27;21:749. doi: 10.1186/s13063-020-04675-7

Fig. 2.

Fig. 2

Thrombin Inhibition Preoperatively (TIP) in Early Breast Cancer Trial flow diagram. In this multi-centre study patients are randomised 1:1 20 mg Rivaroxaban once daily (OD): No Treatment. Randomisation is blinded to pathologists, research laboratory staff and data analysts, but not to patients and clinicians